Literature DB >> 1353667

Iontophoretic study of speed of action of various muscle relaxants.

J C Min1, I Bekavac, M I Glavinovic, F Donati, D R Bevan.   

Abstract

The speed of action of nondepolarizing muscle relaxants is inversely related to potency. The hypothesis that this effect occurs at the end plate was tested in a frog (Rana pipiens) cutaneous pectoris muscle preparation. Brief acetylcholine pulses (10-100 ms) were applied iontophoretically from a central barrel of a triple-barrelled microelectrode located near an end plate. Long pulses (10-200 s) of muscle relaxant (gallamine, rocuronium, d-tubocurarine, atracurium, vecuronium, pancuronium, and doxacurium) were applied from one of two other barrels. The responses were a voltage change at the end plate, measured with an intracellular electrode. To evaluate potency, intracellular voltage changes following iontophoretic acetylcholine pulses were measured after application of various concentrations of muscle relaxants. The following were the equilibrium dissociation constants, which represent concentration of relaxant for 50% inhibition of response (mean plus or minus standard deviation): gallamine, 4.56 +/- 0.44 microM (n = 5); rocuronium, 0.71 +/- 0.09 microM (n = 6); d-tubocurarine, 0.59 +/- 0.07 microM (n = 4); atracurium, 0.31 +/- 0.03 microM (n = 4); vecuronium, 0.23 +/- 0.02 microM (n = 5); pancuronium, 0.18 +/- 0.03 microM (n = 3); doxacurium, 0.11 +/- 0.03 microM (n = 5). Both onset and offset of effect of muscle relaxant proceeded with an exponential time course.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353667     DOI: 10.1097/00000542-199208000-00019

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptors.

Authors:  P G Purohit; R J Tate; E Pow; D Hill; J G Connolly
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

2.  Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.

Authors:  K Yamamoto; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

3.  An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.

Authors:  J H Proost; J M Wierda; D K Meijer
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

Review 4.  Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

5.  Simulation of the kinetics of neuromuscular block: implications for speed of onset.

Authors:  James P Dilger
Journal:  Anesth Analg       Date:  2013-03-01       Impact factor: 5.108

6.  In vitro potency and mode of action of ANQ9040: a novel fast acting muscle relaxant.

Authors:  G Lees; I T Munday; M D Edwards; R M Jones
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

7.  Clinical pharmacology of ORG 7617, a short-acting non-depolarizing neuromuscular blocking agent.

Authors:  L van den Broek; J M Wierda; J H Proost; F D Hommes; S Agoston
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  Waiting time after non-depolarizing relaxants alter muscle fasciculation response to succinylcholine.

Authors:  A C Pinchak; C E Smith; L S Shepard; L Patterson
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

9.  Physiologic-pharmacologic interpretation of the constants in the Hill equation for neuromuscular block: a hypothesis.

Authors:  Vladimir Nigrovic; Anton Amann
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

Review 10.  Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents.

Authors:  Yong Beom Kim; Tae-Yun Sung; Hong Seuk Yang
Journal:  Korean J Anesthesiol       Date:  2017-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.